• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

AstraZeneca said to have explored Bristol Myers merger
Health
AstraZeneca said to have explored Bristol Myers merger
By Dinesh Nair, Michelle F. Davis, Ashleigh Furlong, Kelly Gilblom and BloombergAugust 2, 2026
td
Health
‘It is okay not to be okay’: NFL legend Terrell Davis joins growing roster of athletes partnering with big pharma to raise health awareness
By Joshua HongJuly 29, 2026
Roderick Wong, MD is Managing Partner and Chief Investment Officer of RTW Investments
Commentary
When 10,000 doctors stood up and cheered for a cancer drug — America’s innovation machine made it possible
By Roderick WongJuly 25, 2026
craig
Commentary
Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it
By Craig GarthwaiteJuly 24, 2026
Pharmacy technician Brandy Leroy fills a TPN bag using the ExactaMix Pro Automated Compounding System
Startups & Venture
The FDA’s peptide vote could create telehealth’s next multibillion-dollar market
By Lily Mae LazarusJuly 20, 2026
Sean McClain wears a lab coat
Startups & Venture
Eli Lilly just placed a $40 million bet on the next injectable boom
By Lily Mae LazarusJuly 1, 2026
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
Asia
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
By Nicholas GordonJune 22, 2026
Dr. Shiv Rao speaks
Startups & Venture
Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it
By Lily Mae LazarusJune 11, 2026
Geoffrey von Maltzahn and Kimberly Powell on stage at Fortune Brainstorm Tech
AI
AI drug discovery leaders warn U.S. health funding cuts risk falling behind global rivals
By Lily Mae LazarusJune 10, 2026
Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
Health
Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics
By Madison Muller and BloombergJune 7, 2026
bb
C-Suite
The CEO who loves AI autodidacts — and desperately needs his experts
By Nick LichtenbergJune 3, 2026
Apoha cofounders Anshika Srivastava (left) and Shamit Shrivastava.
AI
Exclusive: Apoha, a startup building AI models for creating new materials, emerges from stealth with $36 million in funding
By Jeremy KahnJune 3, 2026
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
Newsletters
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
By John KellMay 27, 2026
Perceptic cofounders Tilman Flock (left), Zaki Trache (center), and Martin Copes.
AI
Exclusive: Perceptic, a startup automating drug discovery end-to-end for Big Pharma, emerges from stealth with $12 million in seed funding
By Jeremy KahnMay 26, 2026
Trump points as he speaks with his mouth opened wide
Politics
White House estimates Trump’s Big Pharma dealmaking will save Americans $529 billion over the next 10 years
By Josh Boak and The Associated PressMay 5, 2026
1
  • 1
  • 2
  • 3
  • 4
  • 5
...100
Most Popular
Middle East
Iranian officials are worried the U.S. blockade will cause an economic collapse and admit sanctions relief is desperately neededplaceholder alt text
By Jason MaAugust 8, 2026
Real Estate
Meet the 33-year-old CEO betting on boomers chasing their grandkids—and millennials selling their first houseplaceholder alt text
By Nick LichtenbergAugust 8, 2026
Personal Finance
Great disappointment will follow the Great Wealth Transfer as baby boomers pass on just a fraction of their fortune to millennials and Gen Xersplaceholder alt text
By Jason MaAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.